BRCA1 and BRCA2 are genes that help protect the body by fixing damaged DNA and keeping cells healthy. When these genes have changes, or mutations, they don’t work the way they should. This can raise the risk of certain cancers, like breast, ovarian, prostate and pancreatic cancer. These inherited mutations affect about 1 in every 200 to 300 people — over a million in the U.S. alone.

Alicia Logue, MD, associate professor, Department of Surgery, was interviewed for this episode of The Source.   Listen Now

Maria E. Falzone, PhD, assistant professor in the Department of Biochemistry and Structural Biology in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), has received a $150,000 UT Science and Technology Acquisition and Retention (STARs) award from the […]

Mays Cancer Center offers a survivorship program to patients to prevent cancer from reoccurring through interventions and surveillance to help them live well after treatment.

Learn about Mays Cancer Center’s cardio-oncology program and what cancer patients who have cardiovascular conditions can expect.

Kate Lathrop, MD, shares how participating in a clinical trial can play a key role in an expansion of your care team and survivorship.

Listen to one expert highlight the benefits of having a cancer rehabilitation program that focuses on preventing long-term complications that may come from symptoms or side effects related to cancer treatment.

Executive Director Ruben Mesa, MD, explains the benefits of having access to clinical trials and the cutting-edge capabilities they provide for patients in South Texas.

Mark Bonnen, MD, discusses how Mays Cancer Center’s Medical Management Program integrates primary care into cancer care to better support our patients.

Kate Lathrop, MD, explains the advantages of being able to collaborate as an NCI- designated Cancer Center and produce translational research to improve patient care.